These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38015803)

  • 1. Treating Glabellar Lines With Botulinum Toxin: Does Your Patient Need to Frown Steadily?
    Cavallini M; Dell'Avanzato R; Fundarò SP; Urdiales-Gálvez F; Papagni M; Trocchi G; Raichi M; Zazzaron M
    Aesthet Surg J; 2024 Mar; 44(4):421-427. PubMed ID: 38015803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical Injection Guidelines for Glabellar Frown Lines Based on Ultrasonographic Evaluation.
    Kim SB; Kim HM; Ahn H; Choi YJ; Hu KS; Oh W; Kim HJ
    Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomical Proposal for Botulinum Neurotoxin Injection for Glabellar Frown Lines.
    Yi KH; Lee JH; Hu HW; Kim HJ
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-plane injection of botulinum exotoxin A in glabellar frown lines.
    Ozsoy Z; Gözü A; Genç B
    Aesthetic Plast Surg; 2004; 28(2):114-5. PubMed ID: 15170246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position.
    Bertucci V; Green JB; Fezza JP; Brown J; Gallagher CJ; Solish N
    Aesthet Surg J; 2023 Nov; 43(Suppl 1):S10-S18. PubMed ID: 36322141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
    Frampton JE; Easthope SE
    Am J Clin Dermatol; 2003; 4(10):709-25. PubMed ID: 14507232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
    Wu Y; Fang F; Lai W; Li C; Li L; Liu Q; Lu J; Pang X; Sun J; Shi X; Picaut P; Prygova I; Andriopoulos B; Sun Q
    Aesthetic Plast Surg; 2023 Feb; 47(1):351-364. PubMed ID: 36536093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient selection in the treatment of glabellar wrinkles with botulinum toxin type A injection.
    Pribitkin EA; Greco TM; Goode RL; Keane WM
    Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):321-6. PubMed ID: 9076240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B; Ascher B; Fratila A; Monheit GD; Talarico S; Sterry W
    Arch Dermatol; 2006 Mar; 142(3):320-6. PubMed ID: 16549707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines.
    Carruthers JD; Lowe NJ; Menter MA; Gibson J; Eadie N;
    Plast Reconstr Surg; 2003 Sep; 112(4):1089-98. PubMed ID: 12973229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of liquid-type botulinum toxin type A for the management of moderate to severe glabellar frown lines.
    Kim JE; Song EJ; Choi GS; Lew BL; Sim WY; Kang H
    Plast Reconstr Surg; 2015 Mar; 135(3):732-741. PubMed ID: 25719692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown lines.
    Prager W; Rappl T
    J Cosmet Dermatol; 2012 Dec; 11(4):267-71. PubMed ID: 23174049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase III Clinical Study of the Efficacy and Safety of Botulinum Toxin Type A (MASPORT) with DYSPORT for the Treatment of Glabellar Lines.
    Hedayat K; Ehsani AH
    Aesthetic Plast Surg; 2024 Feb; 48(3):324-332. PubMed ID: 38233684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrograde vs spot botulinium toxin facial injection.
    Labbe D; Abdulshakoor A; Fernandez J
    Ann Chir Plast Esthet; 2021 Jun; 66(3):223-233. PubMed ID: 32718771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines.
    Solish N; Kane MAC; Biesman BS; Brown J; Gallagher CJ
    Aesthet Surg J; 2023 Nov; 43(Suppl 1):S1-S9. PubMed ID: 36095026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimally Invasive Corrugator Resection and Backfill Using Self-made Modified Liposuction Needle in the Treatment of Moderate and Severe Glabellar Frown Lines].
    Li Y; Ai MH; Liang ZW; Li M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):821-824. PubMed ID: 31907134
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy and complications of a new technique of Abobotulinum-toxin A (Dysport) injection in patients with glabellar lines.
    Karbassi E; Nakhaee N; Zamanian M
    J Cosmet Dermatol; 2019 Feb; 18(1):55-58. PubMed ID: 29569830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An observational study on glabellar wrinkle patterns in Indians.
    Kamat A; Quadros T
    Indian J Dermatol Venereol Leprol; 2019; 85(2):182-189. PubMed ID: 29620040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines.
    Carruthers A; Carruthers J; Coleman WP; Donofrio L; Flynn T; Gold M; Heinz M; Harrington L; Jones D; McDaniel D; Rohrer T; Schlöbe A; Solish N; Weiss RA
    Dermatol Surg; 2013 Apr; 39(4):551-8. PubMed ID: 23379292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
    Alimohammadi M; Andersson M; Punga AR
    Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.